Furthermore, targeting IRE1–XBP1 and IRE1–STAT3 signaling or preserving lipid composition of the ER membrane by genetic and pharmacological approaches attenuated the pro-tumorigenic ability of TAMs and inhibited tumor progression [43]. The gene discussed is STAT3; the disease is neoplasm.